Molecular Origins of Lung Cancer: Prospects for Personalized Prevention and Therapy

This joint conference by the AACR and the IASLC will address the important issues in lung cancer research. Lung cancer kills more people than breast cancer, prostate cancer, kidney cancer, colon cancer, liver cancer, and skin cancer combined, and is the most common cause of cancer-related deaths in both men and women in the United States. Fortunately, these statistics do not tell the whole story. Thanks to research and improved detection and treatment methods, death rates for lung cancer patients, as for cancer patients overall, are declining. This meeting will discuss the important basic, translational, and clinical work that is improving lung cancer prevention, detection, and treatment. The conference will begin with a Keynote Lecture from Tyler Jacks, President of the AACR and Director of the David H. Koch Institute for Integrative Cancer Research at MIT. Additional topics to be covered include drug design, target identification, early detection, cancer stem cells, microRNAs, genome wide approaches to determining risk and outcome, mouse models, and the tumor microenvironment. The role of cancer advocacy in supporting research will also be an important aspect of this meeting. The AACR and IASLC have designed this conference to promote the advancement of knowledge about lung cancer and the development of novel prevention, early detection, and treatment strategies for it.